For the 3.2 mg dose used here, add 2.5 mL to an 80 mg vial
As an oral preparation for research use, the analytical method for 5amino1mq capsules focuses on the accurate determination of active ingredient content and control of impurity limits, ensuring the purity and stability of the preparation to meet research and quality control requirements
For broader context on aging biology and metabolic decline research, the NIH National Institute on Aging provides authoritative resources on the metabolic changes and epigenetic mechanisms that underlie age-associated obesity and sarcopenia
This compound is not approved as a drug, diagnostic, or dietary ingredient, and is not manufactured, packaged, or marketed for consumption, self-experimentation, clinical application, or any use outside properly designed and ethically approved research protocols.
AOD-9604 + CJC-1295 + Ipamorelin (12mg Blend Vial) Dosage Protocol Lipolytic hGH fragment (AOD-9604) + GHRH analog (CJC-1295) + GH secretagogue (Ipamorelin) in one 12 mg blend research-only, not FDA-approved